XML 38 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes In Shareholders' Equity - USD ($)
Issued capital [member]
Equity Component of Convertible Debentures [Member]
Warrants and Compensation Options [Member]
Contributed Surplus [Member]
Accumulated other comprehensive income [member]
Retained earnings [member]
Beginning balance at Dec. 31, 2018 $ 112,028,194 $ 8,303,738 $ 36,042,754 $ (2,083,514) $ (133,195,932)
IfrsStatementLineItems [Line Items]            
Funds from the exercise of stock options 60,028          
Fair value of stock options exercised 55,950     (55,950)    
Fair value of expired warrants and compensation options        
Fair value of warrants and compensation warrants exercised        
Conversion of convertible debentures          
Exercise of warrants issued in conjunction with debt financing          
Common shares issued to settle accounts payable          
Funds from common shares issued on private placement          
Share issue costs          
Fair value of warrants issued on private placement        
Fair value of broker warrant issued as share issue costs          
Fair value of equity component of convertible debentures   627,511        
Fair value of warrants issued in conjunction with of debt financing     221,620      
Fair value of expired warrants and compensation options          
Fair value of broker warrants issued as share issue costs          
Stock-based compensation       2,812,533    
Fair value effect of conversion of convertible debentures          
Other comprehensive income (loss) attributable to common shareholders - translation adjustment         174,799  
Net loss           (5,952,875)
Total Shareholders’ Equity at Dec. 31, 2019 112,144,172 627,511 8,525,358 38,799,337 (1,908,715) (139,148,807)
IfrsStatementLineItems [Line Items]            
Funds from the exercise of stock options 794,808          
Fair value of stock options exercised 768,356     (768,356)    
Fair value of expired warrants and compensation options 293,642     2,765,630    
Fair value of warrants and compensation warrants exercised 127,964   (127,964)      
Conversion of convertible debentures 369,545          
Fair value of warrants issued on conversion of convertible debentures (146,858)          
Exercise of warrants issued in conjunction with debt financing 221,620          
Common shares issued to settle accounts payable 13,011          
Funds from common shares issued on private placement          
Share issue costs          
Fair value of warrants issued on private placement        
Fair value of broker warrant issued as share issue costs          
Fair value of equity component of convertible debentures   (62,390)        
Fair value of warrants issued in conjunction with of debt financing     (221,620)      
Fair value of expired warrants and compensation options     (2,765,630)      
Fair value of warrants issued on the exercise of convertible debentures     146,858      
Fair value of broker warrants issued as share issue costs          
Stock-based compensation       3,612,945    
Fair value effect of conversion of convertible debentures       (1,877)    
Other comprehensive income (loss) attributable to common shareholders - translation adjustment         (74,497)  
Net loss           (18,169,070)
Total Shareholders’ Equity at Dec. 31, 2020 114,586,260 565,121 5,557,002 44,407,679 (1,983,212) (157,317,877)
IfrsStatementLineItems [Line Items]            
Funds from the exercise of stock options 3,124,392          
Fair value of stock options exercised 2,699,042     (2,699,042)    
Fair value of expired warrants and compensation options 12,994,358     160,470    
Fair value of warrants and compensation warrants exercised 5,351,586   (5,351,586)      
Conversion of convertible debentures 3,571,342          
Fair value of warrants issued on conversion of convertible debentures (1,229,305)          
Exercise of warrants issued in conjunction with debt financing          
Common shares issued to settle accounts payable 13,814          
Funds from common shares issued on private placement 11,815,595          
Share issue costs (1,143,034)          
Fair value of warrants issued on private placement (3,766,007)   3,766,007      
Fair value of broker warrant issued as share issue costs (288,197)          
Fair value of equity component of convertible debentures   (565,121)        
Fair value of warrants issued in conjunction with of debt financing          
Fair value of expired warrants and compensation options     (160,470)      
Fair value of warrants issued on the exercise of convertible debentures     1,229,305      
Fair value of broker warrants issued as share issue costs     288,197      
Stock-based compensation       4,534,370    
Fair value effect of conversion of convertible debentures       550,856    
Other comprehensive income (loss) attributable to common shareholders - translation adjustment         (70,705)  
Net loss           (15,669,093)
Total Shareholders’ Equity at Dec. 31, 2021 $ 147,729,846 $ 5,328,455 $ 46,954,333 $ (2,053,917) $ (172,986,970)